Trade ADRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ADARx Pharmaceuticals, Inc. (ADRX) is trading at US$17.72, up 3.44% today as of Oct 22, 12:29 EDT. The company has a market capitalisation of US$1.74B. Over the past 52 weeks, ADRX has traded between US$16.61 and US$23.21. On Syfe you can trade ADRX with $0 commission and add it to your watchlist.
| Previous close | US$17.13 |
|---|---|
| Market cap | US$1.74B |
| 52-week range | US$16.61 – US$23.21 |
| Volume | 441.51K |
| Exchange | US |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
ADARx Pharmaceuticals, Inc. (ADRX) stock is trading at US$17.72, +3.44% from the previous close of US$17.13.
The market cap for ADARx Pharmaceuticals, Inc. (ADRX) stock is approximately US$1.74B.
The 52-week high for ADARx Pharmaceuticals, Inc. (ADRX) stock is US$23.21.
The 52-week low for ADARx Pharmaceuticals, Inc. (ADRX) stock is US$16.61.
ADARx Pharmaceuticals, Inc. (ADRX) does not currently pay a dividend.
Stay on top of ADRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
